ADVFN Logo
Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
Innate Pharma SA

Innate Pharma SA (IPHA)

2.22
0.06
(2.78%)
Closed July 24 4:00PM
2.22
0.00
(0.00%)
After Hours: 4:02PM

Innate Pharma SA Financial Summary

The current IPHA market cap is 178.61M. The company's latest EPS is EUR -0.0941 and P/E is -22.74.

Quarter End
EUR (€)EUR (€)EUR (€)EUR (€)EUR (€)
Total Revenue
Operating Income
Net Income
Year End December 30 2023 20192020202120222023
EUR (€)EUR (€)EUR (€)EUR (€)EUR (€)
Total Revenue 85.81M71.32M26.5M57.89M61.64M
Operating Income -27.05M-62.08M-54.98M-57.53M-12.67M
Net Income -20.76M-63.98M-52.81M-58.1M-7.57M
Quarter End
EUR (€)EUR (€)EUR (€)EUR (€)EUR (€)
Total Assets
Total Liabilities
Total Equity
Year End December 30 2023 20192020202120222023
EUR (€)EUR (€)EUR (€)EUR (€)EUR (€)
Total Assets 401.36M307.42M267.5M207.86M184.19M
Total Liabilities 183.95M151.45M160.06M153.71M132.29M
Total Equity 217.42M155.98M107.44M54.15M51.9M
Quarter End
EUR (€)EUR (€)EUR (€)EUR (€)EUR (€)
Operating
Investing
Financing
Year End December 30 2023 20192020202120222023
EUR (€)EUR (€)EUR (€)EUR (€)EUR (€)
Operating 34.92M-51.77M-58.46M-19.15M-32.56M
Investing -62.12M-13.37M-917k1.88M20.63M
Financing 77.77M-1.18M26.82M-1.83M-1.97M
Market Cap 178.61M
Price to Earnings Ratio -22.74
Price to Sales Ratio 2.79
Price to Cash Ratio 2.44
Price to Book Ratio 3.32
Dividend Yield -

Share Statistics

Shares Outstanding 80.45M
Average Volume (1 week) 0
Average Volume (1 Month) 0
52 Week Change -
52 Week High -
52 Week Low -
Spread (Intraday) 0.58 (22.31%)

Company Info

Company Name Innate Pharma SA
Address 117 avenue de luminy
marseille, bouches-du-rhone 13009
Website https://www.innate-pharma.com
Industry biological pds,ex diagnstics (2836)

Your Recent History

Delayed Upgrade Clock